Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divis Laboratories Ltd reported Revenues for Q1FY25 of ₹2,118.00 Crores up from ₹1,778.00 Crore year on year, a rise of 19.12%.
Total Expenses for Q1FY25 of ₹1,593.00 Crores up from ₹1,367.00 Crores year on year, a rise of 16.53%.
Consolidated Net Profit of ₹430.00 Crores up 20.79% from ₹356.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹16.20, up 20.81% from ₹13.41 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.